Aprepitant Injectable Emulsion in Patients With COVID-19 (GUARDS-1)

NCT04470622 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
27
Enrollment
INDUSTRY
Sponsor class

Stopped Study was terminated early by Heron, and was not terminated for safety reasons.

Conditions

Interventions

Sponsor

Heron Therapeutics